Guinea-Bissau Suspends Vaccine Trial Amid Ethical Concerns
Kilder
- Nature: Guinea-Bissau suspends US-funded vaccine trial as African scientists question its motives - Nature
- Nature: Harnessing photoenzymatic reactions for unnatural biosynthesis in microorganisms - Nature
- Fiercebiotech: Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials - Fierce Biotech
- Bioworld: Corxel raises $287M series D round to advance oral GLP-1 - BioWorld MedTech
- Bioworld: Researchers develop Revoice for stroke patients - BioWorld MedTech
- Bioworld: Age impacts disease tolerance to sepsis, study shows - BioWorld MedTech
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.